EIC selects 20 biotech and health innovators for European Pavilion at BIO 2023

Brussels, April 5th 2023
Summary
  • The European Innovation Council selected 20 EIC-funded companies to exhibit at BIO International Convention 2023 in Boston from 5 to 8 June.
  • Selection was competitive and based on internationalisation plans, fit with the trade fair and capacity to generate business.
  • Delegates took part in a preparatory online workshop on 4 April covering US market context, logistics and networking strategies.
  • Speakers included BIO's Senior Manager for International Relations, an ENRICH in the USA programme manager and a former OTF participant.
  • The EIC Overseas Trade Fairs Programme 2.0 offers market exposure, mentoring and matchmaking but outcomes depend on follow-up and execution.

EIC delegation heads to BIO 2023 with 20 European biotech and health innovators

The European Innovation Council announced the companies selected to represent the European Pavilion at the BIO International Convention 2023 in Boston. BIO is one of the largest annual gatherings in biotech and pharma and runs this year from 5 to 8 June. The EIC selection follows a competitive evaluation process under the EIC Overseas Trade Fairs Programme 2.0. Selected teams include start-ups, scaleups and SMEs funded by the EIC with technologies spanning digital health, diagnostics, therapeutics, materials and sustainable biotech solutions.

Who was selected and what they bring

The delegation was chosen on three principal criteria. First, the companies had to show clear internationalisation goals for the US or broader global markets. Second, their technologies had to align with the scope of BIO and the expectations of attendees. Third, assessors considered each candidate's capacity to convert exhibition exposure into commercial relationships. The following EIC-backed companies were selected to exhibit at BIO 2023.

CompanyCountryBrief focus or technology area
AcouSortSwedenMedical device or acoustic sorting technologies
Applied NanolayersNetherlandsSurface functionalization and nanolayer coatings for biomedical and industrial uses
Beats MedicalIrelandDigital health platform Colbolt for objective remote clinical assessments
BioiniciaSpainBiotech solutions and process technologies for life sciences
BIOMIMXItalyMedical imaging and diagnostic software solutions
Celeris TherapeuticsAustriaTherapeutics development company
GlycanosticsSlovakiaEarly stage cancer diagnostics using glycan biomarkers
GrapheneaSpainGraphene materials and foundry services with biosensing applications
iLoFPortugalPhotonics and AI platform building an optical 'fingerprint' library for blood based biomarkers
IncircularNetherlandsCircular economy and sustainable biotech solutions
InovotionFranceIn vivo oncology screening assays and early efficacy models
MculeHungaryOnline drug discovery platform integrating purchasable compound databases and modeling tools
MT-actFrancePreclinical spin-off focused on microtubule-targeting therapeutic compounds
NIL TechnologyDenmarkNanofluidics and optical sensing platforms
OcuSimTurkeyOptical diagnostics solutions for ophthalmology including cataracts and glaucoma
Op2lysisFranceTherapeutics or medical technology with a focus on clinical impact
ResistellSwitzerlandUltra-rapid antibiotic susceptibility testing using nanomotion detection
SensiusNetherlandsThermotherapy systems for oncology combining heating with radiation or systemic therapies
SILICOLIFEPortugalBiotech-enabled synthetic biology and precision fermentation for sustainable ingredients
ZECLINICSSpainBiomedical solutions for clinical research and treatment support

Preparatory workshop and guest speakers

Selected delegates joined a one-day online briefing on 4 April. The session combined practical logistics with market intelligence and pitch preparation. The objective was to increase the odds that exhibition time translates into meaningful contacts and deals in the US market.

Marcel Kaminstein, BIO - role and contribution:As Senior Manager for International Relations at BIO, he outlined the scale of networking and partnering opportunities available at the convention and provided an orientation to the event format and partnering tools that organisers provide.
Blandine Chantepie-Kari, ENRICH in the USA - role and contribution:Representing ENRICH in the USA and the Temple University Small Business Development Center, she gave practical market insights on doing business in the United States and advised on how to get the most from BIO as a route into the US biotech ecosystem.
Cor Schepens, Applied Nanolayers - peer perspective:As a former participant in the EIC OTF Programme, Schepens shared candid tips from prior trade fair experience about exhibit preparation, pitching and conducting effective meetings with international counterparts.

What the EIC Overseas Trade Fairs programme provides and what it does not

The EIC OTF Programme is designed to help EIC awardees scale internationally by providing structured support around trade fair participation. Typical services include a place in the European Pavilion, onsite visibility, matchmaking and coaching before and during the event. Previous iterations of the programme have also offered mentoring, pitching slots and in some cases partial reimbursement of participation costs. The programme aims to raise the EU innovation profile in target markets but it does not guarantee commercial outcomes or follow-up investment.

Selection criteria and evaluation process:Companies were evaluated by external experts on their internationalisation plan, alignment with the trade fair, expected impact of participation and commitment of human and financial resources. External assessors also check technology readiness levels and commercial preparedness when ranking applicants.

Technical concepts and jargon explained

Technology Readiness Level (TRL):TRL is a commonly used scale that describes the maturity of a technology from basic research through to deployment. Trade fair selectors and investors use TRL to gauge whether a company is ready to commercialise internationally or needs more validation and regulatory work first.
BIO International Convention - why it matters:BIO is a major industry event that attracts biotech and pharma companies, investors and partnering institutions from around the world. It is a concentrated environment for licensing conversations, partnerships, investor meetings and deal making. For European companies targeting North America, BIO is an important entry point into the US market.
Nanomotion and phenotypic AST (example from Resistell):Nanomotion approaches detect nanoscale vibrations generated by living cells to infer metabolic activity in real time. When combined with machine learning, these measurements can provide ultra-rapid antibiotic susceptibility testing that is independent of culture growth. This differs from standard culture based antibiograms which require bacterial growth and can take days.

Practical next steps and open calls

The EIC also pointed delegates and interested EIC awardees to additional open calls under the OTF Programme 2.0. Applicants should consult the EIC Community platform for the official application forms and deadlines. The calls listed at the time of this announcement included IFA Berlin, Gastech Singapore and GITEX Dubai in 2023.

Trade fairLocationDates
IFA BerlinBerlin, Germany1-5 September 2023
GastechSingapore5-8 September 2023
GITEX 2023Dubai, United Arab Emirates16-20 October 2023

If you have questions about the OTF programme or application process, the EIC Community Helpdesk is the designated contact point. The EIC Community platform contains the full schedule of open calls, programme details and guidance documents.

Implications for companies and the wider EU innovation ecosystem

Participation in high profile trade fairs is an established market development tactic that can accelerate lead generation and visibility. For EIC awardees, the programme offers subsidised access to markets that are otherwise costly to enter. At the same time, trade shows are only one element of international expansion. Converting contacts into commercial partnerships typically requires sustained sales effort, regulatory planning and local market adaptation. Measuring the programme's impact requires tracking tangible follow up such as signed agreements, pilot projects, distribution deals or fundraising that result from trade fair interactions.

From a policy perspective, the OTF Programme sits within a broader EU effort to support deep tech scaling and global presence for European innovators. The EIC plays a visible role in convening and de-risking early internationalisation steps. Observers should however avoid equating inclusion in a pavilion with business success. The true test for participating companies will be their ability to use the fair as a springboard for concrete partnerships and revenue growth.

Further reading and contacts

For background on the EIC OTF Programme 2.0 and ongoing EIC International Trade Fairs activities consult the EIC Community platform and the EIC International Trade Fairs Programme pages. For enquiries about the BIO delegation or the OTF calls, use the EIC Community Helpdesk and select the relevant event category.